{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:53:17Z","timestamp":1790905997191,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.toxlet.2024.04.005","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T06:17:42Z","timestamp":1713939462000},"page":"81-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Roles of AhR\/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy"],"prefix":"10.1016","volume":"396","author":[{"given":"Wei","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2024.04.005_bib1","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s40620-022-01271-7","article-title":"Serum concentrations of free indoxyl and p-cresyl sulfate are associated with mineral metabolism variables and cardiovascular risk in hemodialysis patients","volume":"35","author":"Arcidiacono","year":"2022","journal-title":"J. Nephrol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/mol.63.1.119","article-title":"Mechanism of Rat UDP-Glucuronosyltransferase 1A6 Induction by Oltipraz: evidence for a contribution of the aryl hydrocarbon receptor pathway","volume":"63","author":"Auyeung","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114220","article-title":"Aryl hydrocarbon receptor (AHR)-mediated inflammation and resolution: non-genomic and genomic signaling","volume":"182","author":"Bock","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2018.01.024","article-title":"ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection","volume":"117","author":"Cadenas","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.toxlet.2024.04.005_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2215\/CJN.04730514","article-title":"Association of indoxyl sulfate with heart failure among patients on hemodialysis","volume":"10","author":"Cao","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"10.1016\/j.toxlet.2024.04.005_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/mol.106.025304","article-title":"Aryl hydrocarbon receptor activation produces heart-specific transcriptional and toxic responses in developing zebrafish","volume":"70","author":"Carney","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cbi.2019.02.023","article-title":"Indoxyl sulfate induces myotube atrophy by ROS-ERK and JNK-MAFbx cascades","volume":"304","author":"Changchien","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2024.04.005_bib8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and Pathologic Concentrations of Uremic Toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/03602532.2016.1197240","article-title":"The role of AHR-inducible cytochrome P450s in metabolism of polyunsaturated fatty acids","volume":"48","author":"Hankinson","year":"2016","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.toxlet.2024.04.005_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/ijms23010531","article-title":"Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: a systematic review","volume":"23","author":"Harlacher","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2024.04.005_bib11","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00204-019-02446-1","article-title":"Ablation of aryl hydrocarbon receptor promotes angiotensin II-induced cardiac fibrosis through enhanced c-Jun\/HIF-1\u03b1 signaling","volume":"93","author":"Ichihara","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib12","doi-asserted-by":"crossref","first-page":"16528","DOI":"10.1038\/s41598-020-73633-9","article-title":"Plasma indoxyl sulfate levels predict cardiovascular events in patients with mild chronic heart failure","volume":"10","author":"Imazu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxlet.2024.04.005_bib13","article-title":"Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy","volume":"26","author":"Ke","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib14","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","article-title":"Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?","volume":"31","author":"Lekawanvijit","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.toxlet.2024.04.005_bib15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/toxins8120358","article-title":"Indoxyl sulfate\u2014review of toxicity and therapeutic strategies","volume":"8","author":"Leong","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.toxlet.2024.04.005_bib16","first-page":"318","article-title":"A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia","volume":"76","author":"Lim","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.toxlet.2024.04.005_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114845","article-title":"An overview of aryl hydrocarbon receptor ligands in the Last two decades (2002\u20132022): a medicinal chemistry perspective","volume":"244","author":"Lin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.toxlet.2024.04.005_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.arcmed.2012.08.002","article-title":"Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease","volume":"43","author":"Lin","year":"2012","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.toxlet.2024.04.005_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007525","article-title":"Prevalence of chronic kidney disease in Asia: a systematic review and analysis","volume":"7","author":"Liyanage","year":"2022","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.toxlet.2024.04.005_bib20","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1021\/es062793g","article-title":"Aryl hydrocarbon receptor plays a significant role in mediating airborne particulate-induced carcinogenesis in mice","volume":"41","author":"Matsumoto","year":"2007","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib21","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.toxlet.2024.04.005_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.taap.2019.04.004","article-title":"Biotransformation and oxidative stress responses in rat hepatic cell-line (H4IIE) exposed to organophosphate esters (OPEs)","volume":"371","author":"Mennillo","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/toxins13120909","article-title":"Indoxyl Sulfate Contributes to mTORC1-Induced Renal Fibrosis via The OAT\/NADPH Oxidase\/ROS Pathway","volume":"13","author":"Nakano","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.toxlet.2024.04.005_bib24","doi-asserted-by":"crossref","first-page":"23847","DOI":"10.1074\/jbc.R400004200","article-title":"Role of aryl hydrocarbon receptor-mediated induction of the cyp1 enzymes in environmental toxicity and cancer","volume":"279","author":"Nebert","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2024.04.005_bib25","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/CIRCRESAHA.123.321759","article-title":"Cardiac metabolism in heart failure and implications for uremic cardiomyopathy","volume":"132","author":"Nguyen","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.toxlet.2024.04.005_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev.pa.22.040182.002505","article-title":"2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity","volume":"22","author":"Poland","year":"1982","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.arcmed.2019.12.020","article-title":"Indoxyl Sulfate Contributes to Uremic Sarcopenia by Inducing Apoptosis in Myoblasts","volume":"51","author":"Rodrigues","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.toxlet.2024.04.005_bib28","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/toxins6030934","article-title":"The Aryl Hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease","volume":"6","author":"Sall\u00e9e","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.toxlet.2024.04.005_bib30","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","article-title":"Molecular and cellular mechanisms of cardiovascular disorders in diabetes","volume":"118","author":"Shah","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.toxlet.2024.04.005_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2021.07.001","article-title":"Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): implications for human lung cancer","volume":"76","author":"Stading","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnci\/91.9.779","article-title":"Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"91","author":"Steenland","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.toxlet.2024.04.005_bib33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev-immunol-032713-120245","article-title":"The aryl hydrocarbon receptor: multitasking in the immune system","volume":"32","author":"Stockinger","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1385\/CT:2:4:263","article-title":"Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxia-inducible factor-1alpha in the absence of cardiac hypoxia","volume":"2","author":"Thackaberry","year":"2002","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib35","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/clinchem\/38.8.1429","article-title":"Assessment of urea and other uremic markers for quantification of dialysis efficacy","volume":"38","author":"Vanholder","year":"1992","journal-title":"Clin. Chem."},{"key":"10.1016\/j.toxlet.2024.04.005_bib36","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101530","article-title":"The aryl hydrocarbon receptor as a target of environmental stressors \u2013 Implications for pollution mediated stress and inflammatory responses","volume":"34","author":"Vogel","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.toxlet.2024.04.005_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106989","article-title":"Unraveling the differential impact of PAHs and dioxin-like compounds on AKR1C3 reveals the EGFR extracellular domain as a critical determinant of the AHR response","volume":"158","author":"Vogeley","year":"2022","journal-title":"Environ. Int."},{"key":"10.1016\/j.toxlet.2024.04.005_bib39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.kint.2019.09.029","article-title":"Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease","volume":"97","author":"Walker","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.toxlet.2024.04.005_bib40","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2016-10-744060","article-title":"Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease-associated thrombosis in mice","volume":"129","author":"Yang","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.toxlet.2024.04.005_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145475","article-title":"Indoxyl sulfate reduces Ito,f by activating ROS\/MAPK and NF-\u03baB signaling pathways","volume":"7","author":"Yang","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.toxlet.2024.04.005_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.toxlet.2015.01.021","article-title":"Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK\/UCP2 signaling pathway","volume":"234","author":"Yang","year":"2015","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.toxlet.2024.04.005_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12916-022-02554-3","article-title":"NUPR1 contributes to radiation resistance by maintaining ROS homeostasis via AhR\/CYP signal axis in hepatocellular carcinoma","volume":"20","author":"Zhan","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.toxlet.2024.04.005_bib44","first-page":"393","article-title":"Inhibition of CYP1B1 ameliorates cardiac hypertrophy induced by uremic toxin","volume":"21","author":"Zhang","year":"2020","journal-title":"Mol. Med. Rep."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427424000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427424000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:37:16Z","timestamp":1715996236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427424000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":44,"alternative-id":["S0378427424000687"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.04.005","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles of AhR\/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}